Managing the side effects of sorafenib and sunitinib

[Olga]

Managing the side effects
of sorafenib and sunitinib
Laura S. Wood, RN, MSN, OCN | Cleveland Clinic Taussig Cancer Center, Cleveland, OH
The approval of sorafenib and sunitinib has created a paradigmatic shift in the treatment of metastatic renal cell carcinoma. However, there is a need for effective patient education and early intervention to manage side effects. This article offers a brief overview of the side effects associated with sorafenib and sunitinib as well as guidelines for helping patients resolve their symptoms and a patient education resource box on page 562.
http://www.communityoncology.net/journa ... 309558.pdf